#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Chronic lymphocytic leukaemia Philadelphia chromosome positive Kearns-Sayre syndrome Hypochondroplasia Anaplastic thyroid cancer Thrombocytopenia Small cell lung cancer recurrent Vitamin B12 deficiency High-grade B-cell lymphoma Small cell lung cancer extensive stage Anal cancer Gastroenteropancreatic neuroendocrine tumour disease Squamous cell carcinoma of head and neck Idiopathic intracranial hypertension More trials…

    Learn about Rare Diseases

    Fragile X syndrome Haemophilia B without inhibitors – Trials in Disease Ornithine transcarbamoylase deficiency Glycogen storage disease type V – Basic Information Loeys-Dietz syndrome – Life with Disease Familial amyotrophic lateral sclerosis – Basic Information Factor IX deficiency – Diagnostics IgA nephropathy – Basic Information Chronic granulomatous disease Sarcoidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000044501 Dexchlorpheniramine Orlistat Lib-01 Monohydrate Esomeprazole Rgx-202 Ruzasvir Cdr132L Sodium Febuxostat XELAFASLATIDE FLUORIDE Aavanc80-5'Hotof Vinflunine OXYBUTYNIN HYDROCHLORIDE Fazirsiran Latanoprost Vanzacaftor Sodium Iodide Valganciclovir Sulfonamides, Urea Derivatives More therapies…

    Learn about Your Condition

    Suicidal ideation Gaucher's disease type I Myositis Transplantation complication Uterine leiomyoma Merycism Infective uveitis Hepatitis D Mastocytosis Polyneuropathy Testicular leiomyosarcoma Glioma Nephrotic syndrome Hypertonic bladder Dementia with Lewy bodies More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study Comparing CPX-351 and Chemotherapy for Patients with New Intermediate or High-Risk Acute Myeloid Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Idarubicin
    • Cytarabine
    • Daunorubicin
    France

  • Study on Abatacept for Rheumatoid Arthritis in Patients Responding to Initial TNF Inhibitor Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Abatacept
    France

  • Study on Nalmefene and Placebo for Reducing Cravings in Patients with Gambling Disorder, Sexual Addiction, or Food Addiction

    Recruiting

    3 1 1
    Investigated Diseases:
    • Behavioural addiction
    France

  • Study on the Safety and Effects of ACI-24.060 for Patients with Early Alzheimer’s Disease and Adults with Down Syndrome

    Recruiting

    1 1 1
    Investigated Drugs:
    • Pal1-15 Acetate
    • Izaflortaucipir (18F)
    • Florbetaben (18F)
    Spain

  • Study on the Effectiveness of Dutasteride with Goserelin Acetate and Bicalutamide in Patients with Recurrent or Metastatic Salivary Duct Carcinoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Salivary gland cancer
    Investigated Drugs:
    • Dutasteride
    • Bicalutamide
    • Goserelin Acetate
    The Netherlands

  • Study on How Degarelix and Drug Combination Affect Gut Health in Patients with Prostate Cancer or Benign Prostate Hyperplasia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Benign prostatic hyperplasia
    • Prostate cancer
    Investigated Drugs:
    • Dutasteride
    • Finasteride
    • Tamsulosin Hydrochloride
    Finland
Previous Page
1 … 569 570 571 572 573 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!